Antimicrobial Activities of the Anti-acne Compounds from Natural Sources
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, E.S. | - |
dc.contributor.author | Kim, | - |
dc.contributor.author | Narae, | - |
dc.contributor.author | Lim, Y.-H. | - |
dc.contributor.author | Park, S.W. | - |
dc.date.accessioned | 2021-09-09T00:29:26Z | - |
dc.date.available | 2021-09-09T00:29:26Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1598-642X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/121913 | - |
dc.description.abstract | The in vitro antibacterial activities of anti-acne agents prepared from the extracts of natural sources were investigated against several bacteria including antibiotic-susceptible and -resistant Propionibacterium acnes. SD-1 and SD-2 were prepared with different formulations and they showed strong antibacterial activities. The anti-acne agents completely inhibited the growth of the tested strains at the concentration of 0.5%. There was no difference in antibacterial activity between antibiotic-susceptible and -resistant P. acnes. The inhibitory activities of two agents showed time-dependent manner. In S. aureus, time-kill curve demonstrated 2.8- and 3.4-log]o-unit killing after 8 h with SD-1 and SD-2, respectively. In P. acnes, time-killing curve demonstrated 5.1- and 6. l-logi0-unit killing after 24 h with SD-1 and SD-2, respectively. SD-2 showed stronger antimicrobial activity than SD-1. From these results, we expect that SD-1 and SD-2 have strong antibacterial activities and have advantages for treating acne. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.subject | anti acne agent | - |
dc.subject | clindamycin | - |
dc.subject | dimethyl sulfoxide | - |
dc.subject | acne | - |
dc.subject | antibiotic sensitivity | - |
dc.subject | antimicrobial activity | - |
dc.subject | article | - |
dc.subject | controlled study | - |
dc.subject | nonhuman | - |
dc.subject | Propionibacterium acnes | - |
dc.subject | Staphylococcus aureus | - |
dc.subject | Propionibacterium acnes | - |
dc.subject | Staphylococcus aureus | - |
dc.title | Antimicrobial Activities of the Anti-acne Compounds from Natural Sources | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lim, Y.-H. | - |
dc.identifier.scopusid | 2-s2.0-64949199275 | - |
dc.identifier.bibliographicCitation | Korean Journal of Microbiology and Biotechnology, v.37, no.1, pp.80 - 84 | - |
dc.relation.isPartOf | Korean Journal of Microbiology and Biotechnology | - |
dc.citation.title | Korean Journal of Microbiology and Biotechnology | - |
dc.citation.volume | 37 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 80 | - |
dc.citation.endPage | 84 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001331797 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | anti acne agent | - |
dc.subject.keywordPlus | clindamycin | - |
dc.subject.keywordPlus | dimethyl sulfoxide | - |
dc.subject.keywordPlus | acne | - |
dc.subject.keywordPlus | antibiotic sensitivity | - |
dc.subject.keywordPlus | antimicrobial activity | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | Propionibacterium acnes | - |
dc.subject.keywordPlus | Staphylococcus aureus | - |
dc.subject.keywordPlus | Propionibacterium acnes | - |
dc.subject.keywordPlus | Staphylococcus aureus | - |
dc.subject.keywordAuthor | Anti-acne | - |
dc.subject.keywordAuthor | Antimicrobial activity | - |
dc.subject.keywordAuthor | Propionibacterium acnes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.